Related Experiment Video
Updated: Dec 9, 2025
Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
Evaluation of switch from satellite laboratory to central laboratory for testing of intraoperative parathyroid
Denise Jacob1, Geeta Lal2, Dena R Voss1
1Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Objectives:
The aim of this study was to evaluate testing turnaround time (TAT) and incision to close time in parathyroid surgeries before and after switching intraoperative parathyroid hormone (PTH) testing from a near point of care location to a central clinical laboratory.
Design And Methods:
This retrospective study covered a ten-year period. Both testing locations used the same Roche Diagnostics PTH immunoassay but on different analyzers. The predominant site for surgeries was the main operating rooms (ORs) in an adjacent building, with a limited number of parathyroid surgeries performed at a more distant ambulatory surgery center (ASC). Under ideal conditions, TAT for near point-of-care testing was 20 min, although multiple factors could increase TAT. Incision to close time from the electronic health record was used to define time of surgery.
Results:
A total of 897 unique patients were identified for which 3031 orders for intraoperative PTH were placed (383 unique patients and 1244 orders after switch in testing site). The average total TAT times for testing (mean ± SD) in the central laboratory were 23.9 ± 16.0 min (median, 22 min) for all specimens, 22.8 ± 7.9 min (median, 21 min) for main OR specimens, and 26.4 ± 7.1 min (median, 25 min) for ASC specimens. Incision to close time for parathyroidectomies showed decreases in mean, median, and standard deviation following testing change.
Conclusions:
Surgery time for parathyroidectomies may remain consistent or decrease if intraoperative PTH testing is moved from a near point of care to a central laboratory.
